Cargando…

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study

BACKGROUND: Early diagnosis of prostate cancer improves its prognosis, while it is essential to upgrade screening tools. This study aimed to explore the value of a novel functional magnetic resonance imaging (MRI) technique, namely amide proton transfer (APT)-weighted MRI, combined with serum prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lu, Wang, Lei, Tan, Yuchuan, Dan, Hanli, Xian, Peng, Zhang, Yipeng, Tan, Yong, Lin, Meng, Zhang, Jiuquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826590/ https://www.ncbi.nlm.nih.gov/pubmed/36611191 http://dx.doi.org/10.1186/s40644-022-00515-w

Ejemplares similares

Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
por: Han, Liying, et al.
Publicado: (2022)

A Transfer Learning Approach for Malignant Prostate Lesion Detection on Multiparametric MRI
por: Chen, Quan, et al.
Publicado: (2019)

Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions
por: Aboushousha, Tarek, et al.
Publicado: (2019)

Assessment of Expression of Ki-67 in Benign and Malignant Prostatic Lesions among Sudanese Patients
por: Mohamed, Albasheer Abdelmalik, et al.
Publicado: (2018)

Spectrum of prostatic lesions
por: Aslam, Hafiz Muhammad, et al.
Publicado: (2013)

Three‐dimensional architecture of common benign and precancerous prostate epithelial lesions
por: Verhoef, Esther I, et al.
Publicado: (2019)

Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate
por: Gupta, Veena, et al.
Publicado: (2014)

Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions
por: Ahmed, Eiman Siddig, et al.
Publicado: (2020)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

(18)F Sodium Fluoride PET/CT in Patients with Prostate Cancer: Quantification of Normal Tissues, Benign Degenerative Lesions, and Malignant Lesions
por: Oldan, Jorge D., et al.
Publicado: (2016)

Sclerosing Adenosis of the Prostate—A Benign Lesion Similar to Prostate Cancer: A Case Report and Literature Review
por: Yao, Huibao, et al.
Publicado: (2022)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Prostate Cancer Lesions by Zone and Race: Does Multiparametric MRI Demonstrate Racial Difference in Prostate Cancer Lesions for African American Men?
por: Koller, Christopher R., et al.
Publicado: (2021)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
por: Kim, Jong Min, et al.
Publicado: (2011)

Multiparametric MRI for Localized Prostate Cancer: Lesion Detection and Staging
por: Margolis, Daniel J. A.
Publicado: (2014)

Comparison of Diffusion Kurtosis Imaging and Amide Proton Transfer Imaging in the Diagnosis and Risk Assessment of Prostate Cancer
por: Yin, Huijia, et al.
Publicado: (2021)

A transfer learning nomogram for predicting prostate cancer and benign conditions on MRI
por: Chen, Junhao, et al.
Publicado: (2023)

A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions
por: Liang, Lei, et al.
Publicado: (2021)

Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate
por: Koopaei, Soheila, et al.
Publicado: (2023)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
por: Nath, Chandan Kumar, et al.
Publicado: (2020)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
por: Romppanen, J, et al.
Publicado: (1999)

Magnetic Resonance Image Compilation Was Used in Conjunction with Prostate PI-RADS v2.1 Score Has Diagnostic Relevance for Benign and Malignant Prostate Lesions
por: Xu, Wenjuan, et al.
Publicado: (2022)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

Ebp1 expression in benign and malignant prostate
por: Gannon, Philippe O, et al.
Publicado: (2008)

Evaluation of Molecular Species of Prostate-Specific Antigen Complexed with Immunoglobulin M in Prostate Cancer and Benign Prostatic Hyperplasia
por: Goč, Sanja, et al.
Publicado: (2013)

Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis
por: Zhang, Lei, et al.
Publicado: (2020)

Retracted: Magnetic Resonance Image Compilation Was Used in Conjunction with Prostate PI-RADS v2.1 Score Has Diagnostic Relevance for Benign and Malignant Prostate Lesions
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI
por: Bao, Jie, et al.
Publicado: (2017)

Evaluation of the Efficiency of MRI-Based Radiomics Classifiers in the Diagnosis of Prostate Lesions
por: Li, Linghao, et al.
Publicado: (2022)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
por: Sarwar, Shahana, et al.
Publicado: (2017)

Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases.
por: Borchert, G. H., et al.
Publicado: (1997)

Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia
por: Fu, Shuang, et al.
Publicado: (2018)

Role of diffusion MRI in characterizing benign and malignant breast lesions
por: Palle, Lalitha, et al.
Publicado: (2009)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging
por: Xing, Pengyi, et al.
Publicado: (2021)

Targeting the cancer lesion, not the whole prostate
por: Bedi, Nishant, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjvl5m34db1ktkcfmt88fshava